Abstract
Orlistat (O) is a potent and selective inhibitor of gastrointestinal lipases. The effect on dietary fat absorption following dosing of O at different times relative to meals was investigated in a placebo (P) controlled study in 24 hospitalized healthy males. After a 5-day run-in, to accustom the subjects to a diet of 2400 kcal and 77 g fat per day and to establish baseline faecal fat excretion, subjects received, in four parallel groups of 6. over 8 days three times daily doses of 80 mg O.P.P (group A) or P. 80 mg O.P (group B) or P.P. 80 mg O (group C) or P.P.P (group D) at mid-meal. 1 h and 2 h after mid-meal respectively. Faeces were collected to measure total fat excretion. The mean (s.d.) of faecal fat in percent of dietary fat, after deduction of pre-treatment faecal fat, was (%) 32.8 (8.1), 34.0 (8.8), 26.9 (4.0) and -1.4 (1.7) in groups A. B. C and D respectively. It was concluded that, within the time period investigated, the pharmacological effect of O is not critically dependent on the time of dosing relative to meals.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borgström B. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Biochim Biophys Acta. 1988 Oct 14;962(3):308–316. doi: 10.1016/0005-2760(88)90260-3. [DOI] [PubMed] [Google Scholar]
- Brunner H., Northfield T. C., Hofmann A. F., Go V. L., Summerskill W. H. Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion. Duodenal perfusion studies in healthy subjects. Mayo Clin Proc. 1974 Nov;49(11):851–860. [PubMed] [Google Scholar]
- Garrow J. S. Treating obesity. BMJ. 1991 Apr 6;302(6780):803–804. doi: 10.1136/bmj.302.6780.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hadváry P., Lengsfeld H., Wolfer H. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J. 1988 Dec 1;256(2):357–361. doi: 10.1042/bj2560357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hogan S., Fleury A., Hadvary P., Lengsfeld H., Meier M. K., Triscari J., Sullivan A. C. Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes. 1987;11 (Suppl 3):35–42. [PubMed] [Google Scholar]
- Meyer J. H., Mayer E. A., Jehn D., Gu Y., Fink A. S., Fried M. Gastric processing and emptying of fat. Gastroenterology. 1986 May;90(5 Pt 1):1176–1187. doi: 10.1016/0016-5085(86)90383-5. [DOI] [PubMed] [Google Scholar]
- Sacks F. M., Willett W. W. More on chewing the fat. The good fat and the good cholesterol. N Engl J Med. 1991 Dec 12;325(24):1740–1742. doi: 10.1056/NEJM199112123252411. [DOI] [PubMed] [Google Scholar]